148 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
and strategy ESG initiatives These meetings were attended by the Independent Chair of our Compensation Committee and members of our management team
CONTINUING … since 2019 George Scangos, Ph.D. Former President & CEO, Vir Biotechnology Director since 2017 Vicki Sato, Ph.D. (Independent Chairman) Former
8-K
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. as independent director nominees to stand for election at its 2024 Annual Meeting of Stockholders
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
”). If elected, each of Drs. Bischofberger and Farid will join the Board on such date.
The nomination of the two new independent directors demonstrates Vir’s
S-8
ffs19f9l8f08xsl
26 Feb 24
Registration of securities for employees
4:27pm
S-8
EX-23.1
w2u2 szhi22
26 Feb 24
Registration of securities for employees
4:27pm
S-3ASR
EX-4.6
r7k4i6248fjjpox
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
514fdfh
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-23.1
cddrcfzdwfmnkdw
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-1.2
75jde1oct23uv
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.5
6vpk ogysw
3 Nov 23
Automatic shelf registration
4:33pm
8-K
lt13un pcyy
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
titbuv8d
23 May 23
Submission of Matters to a Vote of Security Holders
4:06pm